Phospholipids pp 279-282 | Cite as

Biodisposition and Histological Evaluation of Topically Applied Retinoic Acid in Liposomal, Cream and Gel Dosage Forms

  • W. C. Foong
  • B. B. Harsanyi
  • M. Mezei


In search for improved dermatological products attempts are being made to design new vehicles or utilize drug carriers to optimize topical therapy. Several reports have indicated that the liposomal form provided higher drug (triamcinolone, progesterone, econazole, minoxidil and local anesthetics) concentration in the skin but similar or lower concentrations in the internal organs, than the conventional dosage forms, i.e., ointment, cream, gel or lotion (3–5). Biocompatibility studies indicated that liposomes are non-toxic and are safe vehicles (2). Topical retinoids have an increasing role in topical therapy. The existing products have many disadvantages, e.g. high degree of irritation and the chance of systemic absorption which may lead to serious side-effects. The objective of the present study was to develop a liposomal retinoid product and to evaluate the in vivo biodisposition and histological effects of retinoic acid applied topically in liposomal, gel and cream form on guinea pig skin.


Cream Form Topical Retinoid Empty Liposome Liposomal Encapsulation Conventional Dosage Form 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Elias, P.M. (1986): Epidermal effects of retinoid: Supramolecular observations and clinical implications. J. Am. Acad. Dermatol. 15:797–809.PubMedCrossRefGoogle Scholar
  2. 2.
    Foong, W.C., Harsanyi, B.B. and Mezei, M. (1989): Effect of liposomes on hamster oral mucosa. J. Biomed. Mater. Res. (in press).Google Scholar
  3. 3.
    Gesztes, A. and Mezei, M. (1988): Topical anaesthesia of the skin by liposome-encapsulated tetracaine. Anesth. Analg. 67:1079–81.PubMedGoogle Scholar
  4. 4.
    Mezei, M. (1988a): Liposomes in the topical application of drugs, in Liposomes as Drug Carriers, G. Gregoriadis, ed., New York, John Wiley & Son, pp 663–677.Google Scholar
  5. 5.
    Mezei, M. (1988b): Multiphase liposomal drug delivery system, U.S. Patent No. 4,761,288.Google Scholar
  6. 6.
    Orfanos, C.E., Ehlert, R. and Gollnick, H. (1987): The Retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 34:459–503.Google Scholar
  7. 7.
    Schiltz, J.R., Lanigan, J., Nabial, W., Petty, B. and Birnbaum, J.E. (1986): Retinoic acid induces cyclic changes in epidermal thickness and dermal collagen and glycosaminoglycan biosynthesis rates. J. Invest. Dermatol. 87 (5): 663–667.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • W. C. Foong
    • 1
  • B. B. Harsanyi
    • 1
  • M. Mezei
    • 2
  1. 1.Faculty of DentistryDalhousie UniversityHalifaxCanada
  2. 2.College of PharmacyDalhousie UniversityHalifaxCanada

Personalised recommendations